Punisyn Pharmaceuticals, Ltd.

• Founded in Israel, 2006

• Pharmaceutical subsidiary of Rimonest Ltd. (www.rimonest.com)

Scientific Team

• Ephraim Lansky, M.D., Ph.D.

• Robert Newman, Ph.D.

• Helena Paavilainen, Ph.D.

• Core product in development: complex pomegranate drug integrating aqueous and lipid pomegranate fractions for treatment of breast cancer

• Qualified scientists and investors invited to contact us: punisyn@gmail.com

Current Scientific Collaborators

• Cardiff University

• University of Michigan

• Northeastern Ohio Universities of Medicine & Pharmacy

• University of New Haven

• MD Anderson Cancer Center

• OOTR (Organization for Oncology and Translational Research)

• Kyungpook University

• University of Ferrara

• Hillel Yaffe Hospital